Caspio releases chart, dashboard apps

Jeff Byers | | Health Exec | Economics
Caspio has made available new chart applications to create visual web-based charts and dashboards for any database and assist users' understanding of large data sets.

Caspio's chart apps combine data search, customizable reporting and publishing capabilities already built into the Mountain View, Calif.-based company’s platform.

Users can embed multiple charts on the same web page to create dashboards with features such as ad hoc search, filtering controls, record drill-down and data download. The charts are compatible with any website, blog, content management system or mobile site and do not utilize Adobe Flash, Caspio added.

Chart application features also include:
  • Various chart types including line, bar, pie, spline, column and step;
  • Data aggregation support for sum, average, counts and min/max; and
  • Customizable chart labels and grouping.

Jeff Byers

Related Content

American Heart Association highlights importance of NIH as battle over Trump funding cuts continues
Federal judge sides with FTC; case against PBMs to move forward
UnitedHealth pushes back against shareholder transparency proposal
Thousands of staff cut from federal health agencies, including CDC and VA
Nonprofit academic hospital receives criticism after running Super Bowl ad
HeartBeam raising $10M for FDA-cleared health tech with public offering

Around the web

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiovascular Business
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”